Big Pharma entered biotech too late. That same mistake can be avoided in personalized medicine. Today, we stand on the brink of the genomic revolution. The world is only beginning to understand how ...

Pfizer’s $100 billion offer for rival AstraZenecais proof that big drug makers are once again seeking out big mergers. It’s a way for them to gain market leverage as governments clamp down on ...

In their research paper “What Fusion Energy Can Learn From Biotechnology,” MIT professors Andrew W. Lo and Dennis G. Whyte proposed five initiatives for accelerating progress in fusion based on ...

Students at Ironwood Ridge High School have the unique opportunity to work at Nighthawk Biotechnology, Inc., which tackles real-world science, teaches students about the biotech industry and even ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The writer was chair of the UK Vaccine Taskforce and is managing partner of SV Health Investors The emergence ...

Drawing parallels with the rise of the biotech industry, MIT faculty propose strategic initiatives and a practical roadmap to propel fusion energy towards commercialization Cambridge, MA, Nov. 04, ...

Kristofer Mussar, PhD, is COO of VectorBuilder and MD of VectorBuilder GmbH, leading global operations and innovation in gene delivery. What if business leaders approached strategy the way scientists ...

Students in Danielle Schroeder's class at Mountain View High School got an introduction to the biotechnology field through a simulated lesson on HIV. Schroeder's human anatomy class took part in a ...